Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like St. Jude Medical Discovers New Cardiac Device Flaws, Issues Patch Update February 7, 2017 Astellas Takes Out Belgium Biotech in Deal Worth $853 Million April 2, 2017 How Gilead's $12 Billion Kite Pharma Deal Has Already Paid Off for Investors September 18, 2017
